NEW YORK (GenomeWeb News) - Affymetrix and Invitrogen said today that Invitrogen has obtained a non-exclusive, worldwide license to a number of Affymetrix patents.
Under the agreement, Invitrogen will now be allowed to "manufacture and sell spotted nucleic acid microarrays in the research field," the companies said. Financial details of the license were not disclosed.
The licensing deal is the third in seven months for Affy. In April, the microarray company licensed patents to Abbott Laboratories to enable it to manufacture and sell comparative genomic hybridization microarrays, readers, and software for research and diagnostics.
Last December, Affy licensed an undisclosed number of patents to Applied Biosystems related to the manufacture, sale, and use of microarrays for gene expression analysis.